alere next generation lateral flow platform , page-2

Guys... I think we are doing ok :)

Below is a summary of some of Anteos current pipeline.

Some of the big targets

- POC1 in excess of $10m a year from one of the most complex and powerful devices in the market
- Alere in excess of $10m a year from the most simple and easily producible type of POC test on the market
- Vaccine manufacturing ($620 m market 2015)
- Stem cell therapy market:($1 b market, 2014)
- imaging ($1.7 b market)
- Bioseparations ($6 b market by 2018) - IMO, much bigger than the previous mentioned combined.
Cleantech + resources - IMO again, much bigger than all the previous listed combined. :)

Not to mention a few of the other projects being investigated by third parties...

- [Worlds most sensitive Troponin assays ($1.2 b market)] ;)
- Cheap microtitre plates ($500 m market 2009)
- multiple applications with gold nanoparticles ($1 b market)
- glass slide applications
- immunoassay plates
- Rapid diagnostic test devices $3.7 B market in 2012
- In vitro diagnostic medical devices
- Point-of-care devices
- Involvement with revolutionary super-sensitive magnetic biosensor technology
- potential future drug royalties (copolymer plastics, gold nanoparticles and the rest...)
- Revolutionary biosensor products and applications
- microarray drug screning/ high throughput screning
- quantum dot research + solar panels
- drug discovery and development
- self-assembling monolayer technology including gold.
- gold coated silica fibres
- nucleotide (DNA) binding applications
- Multiplexing-Immunoassays
- multiplexing DNA/protein microarrays
- Immuno-precipitation is a huge disruptive target.
- multiple single molecule binding projects
- Applications with microscope slides
- Flow cytometry - super-cheap beads (enormous hole to fill IMO)

Other future projects in the pipeline
- Paint adhesion
- marine antifouling
- bio-fuels
- and all the other projects we currently don't know about.

Newly released products on the market and products coming very shortly
- cheapest streptavidin beads/plates on the market
- game-changing streptavidin slides possibly launching soon.
- disruptive paramagnetic beads on the market
- disruptive unique biosensor product on the market
- disruptive, revolutionary and unique universal binding kit coming out of beta phase soon :D
- disruptive protein A/G magnetic beads coming 100x cheaper than anything else on market.
- the other 4-6 products releasing this year.


- One particular sub-section of bioseparations is worth mentioning: paramagnetic nano/micro beads and the inevitable competition vs Life technologies dynabeads product range (which was purchased by Thermo for $13.6 b... Two of the best-selling dynabeads are protein A and G. These are completely and utterly left in the dust with Anteo's beads IMO.


What value does ADO hold?
- 100+ current projects, and growing.
- growing numbers of business staff + scientists
- many layers of patents, more coming.
- dozens of disruptive fields of applications known
- multiple ongoing projects with multi-$b companies
- 5-11 products of their own released/releasing this year to fill market gaps
- +40 of other companies products for sale.
- Disruptive magnetic bioseparations technology.
- Formed/forming international distribution networks with Europe, China, Japan, US & Aus.
- Big Deals in the pipeline - POC1(Philips), Alere, POC3, Chinese IVD (some delays here), Luminex? (speculation), Roche (Speculation) & others?.
- Approx. $8 million in the bank, an all time high.
- all time high revenues
- Possibility to be indefinitely cash flow positive in the near future stated by the CEO.

I think we are doing ok :)

DYOR.
any queries [email protected]